Page last updated: 2024-12-11

ici 153110

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ICI 153110: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6439810
MeSH IDM0178259

Synonyms (15)

Synonym
unii-o51bp2cbj2
87164-90-7
o51bp2cbj2 ,
ici-153110
(e)-4,5-dihydro-6-(2-(4-pyridinyl)ethenyl)-3(2h)-pyridazinone
3(2h)-pyridazinone, 4,5-dihydro-6-(2-(4-pyridinyl)ethenyl)-, (e)-
ici 153110
4,5-dihydro-6-((1e)-2-(4-pyridinyl)ethenyl)-3(2h)-pyridazinone
3(2h)-pyridazinone, 4,5-dihydro-6-((1e)-2-(4-pyridinyl)ethenyl)-
HY-100239
CS-0018390
ici153110
6-[(e)-2-(4-pyridinyl)vinyl]-4,5-dihydro-3(2h)-pyridazinone
DTXSID801338836
AKOS040733418

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"ICI 153,110 and ICI 170,777, two pyridyl diazinone cardiotonic agents, produced a different profile of effects on hepatic microsomal mixed function oxidase enzymes following multiple oral dosing to rats and dogs; these differences may be related to the molecular dimensions of the two molecules."( Different inhibition and induction profiles of hepatic drug metabolism in rats and dogs by two structurally related pyridyl diazinone cardiotonic agents.
McKillop, D; Pickup, KJ, 1991
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.66 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]